Solifenacin succinate (VESIcare) : overactive bladder therapy
Kosier, J.H.; Combest, W.; Newton, M.
Urologic Nursing 26(6): 496-497
2006
ISSN/ISBN: 1053-816X PMID: 17253085 Document Number: 604059
Document emailed within 1 workday
Related Documents
Cardozo, L.; Lisec, M.; Milard, R.; Van Vierssen Trip, O.; Kuzmin, I.; Drogendijk, T.E.; Huang, A.M. 2007: A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder Akusherstvo i Ginekologiia 46(5): 55-57Oresković, S.; But, I.; Banović, M.; Goldstajn, M.S. 2012: The efficacy and safety of solifenacin in patients with overactive bladder syndrome Collegium Antropologicum 36(1): 243-248
Rahardjo, H.E.; Syahputra, F.A.; Islianti, P.I.; Matondang, F.A. 2018: Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: the SOLUTION Randomized Controlled Trial Acta Medica Indonesiana 50(3): 200-207
Shen, Y-Zhang.; Lin, X.; Lin, Q. 2012: Overactive bladder after transurethral resection of prostate treated with electroacupuncture therapy and tolterodine Zhongguo Zhen Jiu 32(5): 404-408
Soontrapa, S.; Ruksakul, W.; Nonthasood, B.; Tappayuthpijarn, P. 2003: The efficacy of Thai capsaicin in management of overactive bladder and hypersensitive bladder Journal of the Medical Association of Thailand 86(9): 861-867
Goto, M.; Kato, K.; Kondo, A.; Otani, T.; Takita, T.; Kobayashi, M. 1988: Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial Hinyokika Kiyo. Acta Urologica Japonica 34(3): 541-550
Kubota, Y.; Sasaki, S.; Kojima, Y.; Hayase, M.; Kohri, K. 2007: Overactive bladder in female and new strategy Hinyokika Kiyo. Acta Urologica Japonica 53(6): 435-439
Golomb, J. 2000: Treatment of the overactive bladder with detrusitol Harefuah 139(11-12): 467-470
Nowara, A.; Witek, A.; Wilk, K. 2007: Diagnostic and treatment of overactive bladder Ginekologia Polska 78(7): 549-553
Kul'chavenia, E.V.; Breusov, A.A.; Kholtobin, D.P. 2011: Overactive bladder as a cause of sexual dysfunction Urologiia 5: 87-89
Prasopsanti, K.; Santi-Ngamkun, A.; Pornprasit, K. 2007: Estimated cost of overactive bladder in Thailand Journal of the Medical Association of Thailand 90(11): 2316-2320
Epstein, B.J.; Gums, J.G.; Molina, E. 2006: Newer agents for the management of overactive bladder American Family Physician 74(12): 2061-2068
Khaled, S.M.; Elhilali, M. 2003: Role of 5-HT receptors in treatment of overactive bladder Drugs of Today 39(8): 599-607
Kupriyanov, Y.A.; Kasyan, G.R.; Pushkar, D.Y. 2018: A role of fesoterodine in treatment of overactive bladder Urologiia 6: 155-162
Lajiness, M.J. 2010: Gelnique (oxybutynin chloride) 10% gel for overactive bladder Urologic Nursing 30(4): 253-254
Nowara, A.; Witek, A.; Wilk, K. 2007: Overactive bladder--definition, epidemiology, pathogenesis Ginekologia Polska 78(6): 484-487
Löfgren, O. 2005: Women's "overactive" bladder--a not-evidence-based condition? Lakartidningen 102(42): 3060
Patterson, A. 2011: Behaviour change to treat overactive bladder syndrome Nursing Times 107(46): 16; 18-19
Ogushi, T.; Takahashi, S. 2007: Effect of Chinese herbal medicine on overactive bladder Hinyokika Kiyo. Acta Urologica Japonica 53(12): 857-862
Al'-Shukri, S.K.; Kuz'min, I.V. 2008: Assessment of symptoms severity in patients with overactive bladder Urologiia 6: 37-40